| Time After Starting | Time After Stopping | ALT (U/L) | Alk P (U/L) | GGT (U/L) | Bilirubin (mg/dL) | Other |
|---|---|---|---|---|---|---|
| Pre | Pre | 16 | 14 | 0.4 | Tolvaptan started | |
| 123 days | Pre | 46 | 196 | 31 | 0.5 | |
| 166 days | Pre | 570 | 358 | 274 | 0.5 | Symptomatic |
| 177days | Pre | 332 | 262 | 246 | 0.5 | |
| 190 days | Pre | 159 | 215 | 199 | 0.6 | |
| 202 days | 0 | 882 | 338 | 323 | 1.4 | Tolvaptan stopped |
| 207 days | 5 days | 809 | 316 | 244 | 4.1 | |
| 213 days | 11 days | 598 | 325 | 206 | 7.6 | |
| 222 days | 22 days | 200 | 240 | 189 | 2.0 | |
| 232 days | 32 days | 57 | 170 | 124 | 1.8 | |
| 249 days | 49 days | 30 | 62 | 1.1 | ||
| Normal Values | <35 | <350 | <50 | <1.2 | ||
From: Tolvaptan
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.